Anti-HIV bnAbs May Provide Long-Lasting Protection Against HIV Infection (IMAGE)

Scripps Research Institute

Anti-HIV bnAbs May Provide Long-Lasting Protection Against HIV Infection

Caption

This computer-generated graphic depicts immune system proteins called broadly neutralizing antibodies (bnAbs; colored) binding to different regions on the HIV envelope protein on the surface of the virus (white). Antibody binding to the envelope protein prevents the virus entering host cells and causing infection. Supported by NIH funding, the Scripps Research-led Consortium for HIV/AIDS Vaccine Development (CHAVD) is developing sequential vaccines designed to elicit anti-HIV bnAbs.

Credit

Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.